Skip to main content
. 2018 Sep 6;8:13335. doi: 10.1038/s41598-018-31541-z

Figure 6.

Figure 6

T. cruzi fused-cell hybrids present increased survival rate after co-treatment with hygromycin B or neomycin. Fused-cell hybrids survival rates were assessed 72 h after treatment with hygromicin B and/or neomycin. Fused-cell hybrids are resistant to both hygromycin B and neomycin, and parental cells (harboring only hygromycin B or neomycin resistant genes) showed marked sensitivity when co-incubated with both antibiotics.